2019 annual financial data
Marker Therapeutics 2019 Net margin
Direct answer
Net margin was -10,050.92%.
Operating income was -22,528,806 USD and net income was -21,427,964 USD.
Operating cash flow was -18,284,293 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 213,194 USD
- Operating income
- -22,528,806 USD
- Net income
- -21,427,964 USD
- Operating cash flow
- -18,284,293 USD